In this week’s roundup: a big digital health week at FDA; Congress addresses user fees; EU notified body news; updates from India, Singapore, and China; US and Canada take steps back on emergency COVID-19 test policies; FDA guidance and CMS coverage news; and dates to remember.
Welcome to MyStrategist
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market PathwaysStart Trial
Bubble Bursts for Digital Health: Economic Woes, High Valuations Weigh Down Funding in the First Half of 2022
Recent digital health funding and exit data clearly mark a return to more historical norms as the frothy atmosphere that prevailed in 2021 gives way to more circumspection, bringing the sector back down to earth.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.Learn More
CMS finalizes its indefinite delay of a radiation oncology bundled payment program. Excerpted from Pathways' Pick of the Week August 31: EU Capacity-Building, RadOnc Model on Thin Ice, and More